Is tretinoin comedogenic?
Short answer
Conflicting evidence: Conflicting or context-dependent evidenceThe 1984 rabbit ear assay listed a tretinoin cream among therapeutic products that behaved comedogenically, while tretinoin itself is a first-line comedolytic — a treatment used to clear comedones. On the reviewed sources the finding points at that cream's vehicle rather than at the retinoid, and it comes from an animal screening model later reported to overreact. This entry is not a reason to alter a prescribed treatment; that decision belongs to your prescriber.
Recorded as Tretinoin · dataset record tretinoin · reviewed 2026-08-06
What the evidence actually is
The material was applied to animal skin — in this dataset, a rabbit ear assay. It is a screening model, and the human-assay literature reports that it overreacts to comedogenic materials relative to human testing.
What the sources report
The cited rabbit ear assay identified a tretinoin cream among the therapeutic products that behaved comedogenically, while tretinoin itself is a first-line comedolytic treatment. The finding points at the vehicle rather than the active.
What this does not cover
The cited concern is attached to a specific cream formulation, not to the active ingredient in general, and the model is an animal one reported to overreact. This entry is not a reason to alter a prescribed treatment; that is a decision for your prescriber.
Why people ask about Tretinoin
Tretinoin is often the point at which someone starts reading ingredient lists closely, because early weeks on it commonly involve a period of worsening before improvement. Someone in that window searches the ingredient, finds a comedogenic flag attached to it, and has an explanation that fits what they are seeing. The flag and the experience are not connected in the sources, but they arrive at the same moment.
Where the circulating rating for Tretinoin comes from
The number in circulation traces to Fulton 1984, which tested finished therapeutic products in the rabbit ear alongside cosmetics and raw ingredients. What was tested there was a cream, and creams carry emollients, thickeners and solvents that the assay does not distinguish from the active. Reducing that to a rating on the retinoid attributes a formulation result to the molecule. Draelos and DiNardo's 2006 human-assay work is the direct counterweight: finished products formulated with ingredients previously identified as comedogenic were not necessarily comedogenic themselves.
Names Tretinoin appears under
Declared as Tretinoin, also written as all-trans retinoic acid or retinoic acid. It is a prescription retinoid in most markets and is not the same as retinol, retinaldehyde, adapalene or the retinyl esters sold in cosmetics, each of which is a separate declared material. This project does not carry a result from one of those across to another on the strength of a shared family.
Recognised in this dataset as Tretinoin, and through the recorded aliases all-trans retinoic acid, retinoic acid. Matching is exact: there is no fuzzy matching anywhere in this tool, so a name not listed here is reported as unrecognised rather than guessed at.
Questions about tretinoin
Is the tretinoin purge the same thing as it being comedogenic?
No, and nothing reviewed here connects the two. The sources in this dataset contain a comedogenicity screening result for a cream formulation; they do not describe the early-treatment worsening people call purging, and this project does not offer an account of it. The two are separate questions that happen to surface in the same search.
Does this mean my tretinoin cream is causing breakouts?
It does not establish that. The cited result is an animal-model screening signal attached to a cream tested in 1984, not a finding about the product you were prescribed. The 2016 human-assay methodology work reports that this model overreacts relative to human testing, and the 2006 human work found finished products often do not behave the way their flagged ingredients predict.
Is tretinoin the same as retinol for this question?
No. They are different declared materials with different records, and this dataset does not transfer a comedogenicity result between them. A rating found for one is not evidence about the other.
Sources cited on this page
These are the sources attached to this record. Nothing on this page is drawn from anything else.
Comedogenicity of current therapeutic products, cosmetics, and ingredients in the rabbit ear
Fulton JE Jr, Pay SR, Fulton JE 3rd. Journal of the American Academy of Dermatology, 1984. Peer-reviewed. doi:10.1016/s0190-9622(84)80050-x
Rabbit ear assay. This is the historical origin of most ingredient-level comedogenicity lists in circulation today. The assay is a screening model in animal skin, not a measurement of how a finished cosmetic behaves on a human face. Later work (see src-baek-2016) reports that this model overreacts relative to human testing.
A re-evaluation of the comedogenicity concept
Draelos ZD, DiNardo JC. Journal of the American Academy of Dermatology, 2006. Peer-reviewed. doi:10.1016/j.jaad.2005.11.1058
Applied a modification of the Mills and Kligman human assay to finished cosmetic products formulated with ingredients previously identified as comedogenic. Reported that finished products using comedogenic ingredients are not necessarily comedogenic. This is the single most important source in this dataset: it is the direct evidence that an ingredient-level match cannot be converted into a finished-product conclusion.
Acne: Why won't my acne clear?
American Academy of Dermatology Association, 2026. Professional body.
Consumer guidance from a dermatology professional body. Advises choosing products labelled non-comedogenic while also noting such products can still cause acne in some people. Cited for interpretation guidance, not for ingredient-level classification.
Record reviewed 2026-08-06 by pore-checker prototype dataset compilation (not clinically reviewed).